Related Experiment Video
Updated: Apr 18, 2026
09:57
Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
10.2K
Platelet-derived chemokines in atherosclerosis.
J Duchene1, P von Hundelshausen
1Dr. Johan Duchene, Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Pettenkoferstr. 8a, 80336 München, Germany, Tel. 089/440 05-46 71; Fax -43 52,
Hamostaseologie
|January 17, 2015
Summary
Platelets release inflammatory chemokines that recruit leukocytes, driving atherosclerosis development. This review explores platelet-derived chemokines
Area of Science:
- Cardiovascular Biology
- Immunology
- Inflammation Research
Background:
- Activated platelets contribute to thrombotic events and atherosclerotic lesion development.
- Platelets release pro-inflammatory mediators, including chemokines, upon activation.
Purpose of the Study:
- To review recent findings on the roles of platelet-derived chemokines.
- To elucidate the effects of these chemokines on leukocyte recruitment and function in atherosclerosis.
Main Methods:
- Literature review of current research on platelet function and chemokines in atherosclerosis.
- Analysis of studies investigating chemokine signaling pathways and leukocyte interactions.
Main Results:
- Platelet-derived chemokines are crucial for recruiting leukocytes to atherosclerotic lesions.
- These chemokines influence leukocyte activation, differentiation, proliferation, and apoptosis.
- Specific chemokines released by platelets have distinct effects on inflammatory processes.
Conclusions:
- Platelet chemokines are key mediators in the inflammatory aspects of atherosclerosis.
- Targeting platelet-derived chemokines may offer novel therapeutic strategies for atherosclerosis.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
1.0K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
01:30Atherosclerosis I: Introduction
2.2K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
01:38Inflammation
65.9K
Overview
65.9K
01:22Formation of the Platelet Plug
11.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
11.1K
01:30Peripheral Artery Disease I: Introduction
650
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
650
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K